Form 4: Bausch & Lomb CEO Brent Saunders Reports Stock and Option Grants

CEO Brent Saunders reports receiving restricted stock units and stock options from Bausch & Lomb on February 28, 2024.

Summary

• On February 28, 2024, Brent L Saunders, CEO and Chair of Bausch & Lomb Corp [BLCO], reported transactions related to the company's stock.
• Saunders was granted 187,919 restricted stock units (RSUs) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
• These RSUs are scheduled to vest in equal installments over the first three anniversaries of the grant date, contingent upon continued service.
• Vested RSUs will be settled in common shares of Bausch & Lomb Corporation.
• Saunders also received stock options to purchase 569,105 common shares under the same plan.
• The exercise price for these options is $16.85.
• The stock options are scheduled to vest in equal installments over the first three anniversaries of the grant date and will expire ten years from the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grants are standard practice and incentivize management, but don't represent a major shift in the company's outlook.

Positives

• The grant of RSUs and stock options aligns the CEO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs and stock options.

Industry Context

Stock option and RSU grants are a common form of executive compensation in publicly traded companies, designed to incentivize performance and align management interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are common in the pharmaceutical and medical device industries.
• Companies like Johnson & Johnson, Novartis, and AbbVie also utilize similar incentive plans to reward and retain their top executives.
• The vesting schedules and exercise prices are generally structured to align with industry benchmarks for performance-based compensation.

Stakeholder Impact

• Shareholders may view the grants positively as they align management's interests with the company's long-term success.
• Employees may see the grants as a sign of confidence in the company's future.

Key Dates